Evogene Ltd Ord (EVGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,161 | -5,433 | -2,989 | -18,054 | -15,800 |
| Depreciation Amortization | 1,870 | 1,256 | 905 | 2,975 | 1,077 |
| Accounts receivable | 1,627 | 1,306 | -82 | 191 | -670 |
| Accounts payable and accrued liabilities | -1,319 | -1,178 | -1,136 | -1,093 | -500 |
| Other Working Capital | -996 | -597 | -1,798 | -3,313 | -2,218 |
| Other Operating Activity | -3,837 | -2,837 | -82 | -406 | 2,972 |
| Operating Cash Flow | $-10,816 | $-7,483 | $-5,182 | $-19,700 | $-15,139 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -7,400 | -3,328 | -2,326 | 10,190 | 2,417 |
| PPE Investments | -98 | -123 | -122 | -568 | -294 |
| Other Investing Activity | 14,973 | 17 | 2 | 0 | -1,259 |
| Investing Cash Flow | $7,475 | $-3,434 | $-2,446 | $9,622 | $864 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 2 | N/A | N/A |
| Debt Issued | -10,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 4,283 | 4,283 | N/A | 5,623 | 5,623 |
| Other Financing Activity | -629 | -293 | -161 | -967 | -761 |
| Financing Cash Flow | $-6,346 | $3,990 | $-159 | $4,656 | $4,862 |
| Exchange Rate Effect | 12 | 25 | -19 | -49 | -42 |
| Beginning Cash Position | 15,301 | 15,301 | 15,301 | 20,772 | 20,772 |
| End Cash Position | 5,626 | 8,329 | 7,495 | 15,301 | 11,317 |
| Net Cash Flow | $-9,675 | $-6,972 | $-7,806 | $-5,471 | $-9,455 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,816 | -7,483 | -5,182 | -19,700 | -15,139 |
| Capital Expenditure | -129 | -123 | -122 | -626 | -304 |
| Free Cash Flow | -10,945 | -7,606 | -5,304 | -20,326 | -15,443 |